GENTIAN DIAGNOSTICS ASA financials
GENTIAN DIAGNOSTICS ASA
5967007LIEEXZXHNM861 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Gross profit | NOK 82.8M | NOK 64.2M |
| Other income | NOK 4.6M | NOK 7.2M |
| Operating profit (EBIT) | NOK 15.7M | -NOK 12.8M |
| Net finance income / (cost) | NOK 4.3M | NOK 2.4M |
| Finance costs | NOK 2.5M | NOK 3.4M |
| Profit before tax | NOK 20.1M | -NOK 10.4M |
| Income tax expense | -NOK 25.2M | NOK 282.0K |
| Profit for the year | NOK 45.3M | -NOK 10.6M |
| Total comprehensive income | NOK 44.8M | -NOK 10.6M |
| Per share | ||
| Basic EPS | NOK 2.94 | NOK -0.69 |
| Diluted EPS | NOK 2.87 | NOK -0.69 |
| Free cash flow / share | NOK 0.77 | NOK 0.94 |
| Cash flow statement | ||
| Net cash from operating activities | NOK 13.5M | NOK 15.5M |
| Net cash from investing activities | -NOK 10.9M | -NOK 4.9M |
| Purchase of PP&E (capex) | NOK 1.4M | NOK 955.0K |
| Purchase of intangibles | NOK 9.6M | NOK 3.5M |
| Net cash from financing activities | -NOK 5.0M | -NOK 4.6M |
| Lease liability payments | NOK 5.0M | NOK 4.6M |
| Net change in cash | -NOK 2.4M | NOK 6.0M |
| Balance sheet | ||
| Total assets | NOK 229.7M | NOK 181.0M |
| Non-current assets | NOK 67.7M | NOK 39.3M |
| Property, plant & equipment | NOK 6.3M | NOK 7.8M |
| Right-of-use assets | NOK 7.8M | NOK 10.3M |
| Current assets | NOK 162.0M | NOK 141.7M |
| Trade & other receivables | NOK 31.3M | NOK 17.0M |
| Cash & equivalents | NOK 84.7M | NOK 87.6M |
| Total equity | NOK 194.1M | NOK 146.6M |
| Non-current liabilities | NOK 5.5M | NOK 9.1M |
| Lease liabilities (non-current) | NOK 5.5M | NOK 9.0M |
| Current liabilities | NOK 30.1M | NOK 25.3M |
| Lease liabilities (current) | NOK 4.5M | NOK 4.0M |
| Deferred tax liabilities | NOK 0 | NOK 73.0K |
| Derived metrics | ||
| Free cash flow | NOK 12.1M | NOK 14.5M |
| Operating margin | 10.3% | -9.4% |
| Net margin | 29.8% | -7.9% |
| Return on equity | 23.3% | -7.3% |
| Cash conversion ratio | 0.30× | -1.45× |
| Capex coverage | 9.77× | 16.19× |
| Other reported items | ||
| Additional Paidin Capital | NOK 20.9M | NOK 18.3M |
| Adjustments For Decrease Increase In Inventories | -NOK 8.8M | NOK 2.7M |
| Adjustments For Decrease Increase In Trade Account Receivable | -NOK 11.7M | -NOK 1.2M |
| Adjustments For Depreciation and Amortisation Expense | NOK 9.0M | NOK 9.6M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | NOK 0 | NOK 6.5M |
| Adjustments For Increase Decrease In Trade Account Payable | NOK 2.8M | -NOK 878.0K |
| Adjustments For Sharebased Payments | NOK 2.6M | NOK 3.0M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | NOK 0 | NOK 390.0K |
| Cost of Merchandise Sold | NOK 69.3M | NOK 70.9M |
| Current Payables On Social Security and Taxes Other Than Income Tax | NOK 6.2M | NOK 4.6M |
| Deferred Tax Assets | NOK 25.2M | NOK 0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -NOK 462.0K | NOK 61.0K |
| Equity and Liabilities | NOK 229.7M | NOK 181.0M |
| Finance Income | NOK 6.9M | NOK 5.8M |
| General and Administrative Expense | NOK 21.7M | NOK 25.1M |
| Increase Decrease Through Sharebased Payment Transactions | — | NOK 3.0M |
| Intangible Assets Other Than Goodwill | NOK 28.5M | NOK 21.2M |
| Inventories Total | NOK 45.9M | NOK 37.1M |
| Issued Capital | NOK 1.5M | NOK 1.5M |
| Liabilities | NOK 35.6M | NOK 34.4M |
| Noncurrent Financial Assets | NOK 0 | NOK 101.0K |
| Other Comprehensive Income | -NOK 454.0K | NOK 75.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -NOK 454.0K | NOK 75.0K |
| Other Current Liabilities | NOK 12.8M | NOK 13.0M |
| Research and Development Expense | NOK 21.9M | NOK 36.1M |
| Retained Earnings | -NOK 122.2M | -NOK 167.0M |
| Revenue From Contracts With Customers | NOK 152.1M | NOK 135.2M |
| Sales and Marketing Expense | NOK 28.1M | NOK 23.1M |
| Share Premium | NOK 293.8M | NOK 293.8M |
| Trade and Other Current Payables To Trade Suppliers | NOK 6.5M | NOK 3.7M |
Every line item above is a fact tagged in GENTIAN DIAGNOSTICS ASA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (NOK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.